Abstract
This prospective study was conducted to evaluate the treatment outcome after stereotactic radiosurgery (SRS) alone with special attention to its influence on intracranial freedom from progression (FFP), local control, time to whole brain radiotherapy (WBRT), and survival. Forty-one patients with brain metastases who met the inclusion criteria were enrolled in this prospective cohort and treated by SRS alone between January 1998 and September 2001. The overall local control rate was 76%. The one year actuarial intracranial FFP was 33%. Ten patients (24%) had relapse at treated site. Twenty-three patients (56%) had intracranial progression with a median time of 4.25 months (1–24.6). Salvage radiotherapy was given in 21 patients (51%). Only 12 (29%) patients required WBRT with the median time to WBRT after SRS of 4.85 months. Nine patients (22%) underwent additional SRS at the median time of 5 months after the first procedure. The median survival was 10 months. At the time of follow up, 16 patients (39%) were still alive with a range of 6–31 months. This prospective study suggests that the omission of WBRT in the initial treatment of patients with SRS for four or less brain metastases may allow up to 70% of patients to avoid WBRT.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Posner JB: Management of central nervous system metastases. Semin Oncol 4: 81–91, 1997
Sneed PK, Larson DA, Wara WM: Radiotherapy for cerebral metastases. Neurosurg Clin North Am 7: 505–515, 1996
Flickinger JC, Kondziolka D, Lunsford LD, Coffy RJ, Goodman ML, Shaw EG, Hudgins WR, Weiner R, Harsh GR, Sneed PK: A multi-institutional experience with stereotactic radiosurgery for solitary brain metastasis. Int J Radiat Oncol Biol Phys 28: 797–802, 1994
De Salles AAF, Hariz M, Bajada CL, Goetsch ST, Bergenheim T, Selch M, Holly FE, Solberg T, Becker DP: Comparison between radiosurgery and stereotactic fractionated radiation for the treatment of brain metastases. Acta Neurochir 58: 115–118, 1993
Laing RW, Warrington AP, Hines F, Graham JD, Brada M: Fractionated stereotactic external beam radiotherapy in the management of brain metastases. Eur J Cancer 10: 1387–1391, 1993
Mehta MP, Boyd TS, Sinha P: The status of stereotactic radiosurgery for cerebral metastases in 1998. J Neurosurg 1: 17–30, 1998
Joseph J, Adler JR, Cox RS, Hancock SL: Linear accelerator based stereotactic radiosurgery for brain metastases: the influence of number of lesions on survival. J Clin Oncol 14: 1085–1092, 1996
Marcou Y, Lindquist C, Adams C, Retsas S, Plowman PN: What is the optimal therapy of brain metastases? Clin Oncol 13: 105–111, 2001
De Angelis LM, Mandell LR, Thaler HT: The role of postoperative radiotherapy after resection of single brain metastases. Neurosurgery 24: 798–805, 1989
De Angelis LM, Delattre JY, Prosner JB: Radiation induced dementia in patients cured of brain metastases. Neurology 39: 789–796, 1989
Fuller BG, Kaplan ID, Adler J, Cox RS, Bagshaw MA: Stereotacxic radiosurgery for brain metastases: the importance of adjuvant whole brain irradiation. Int J Radiat Oncol Biol Phys 23: 413–418, 1992
Mehta MP, Rozenthal JM, Levin AB, Mackie TR, Kubsad SS, Gehring MA, Kinsella TJ: Defining the role of radiosurgery in the management of brain metastases. Int J Radiat Oncol Biol Phys 24: 619–625, 1992
Mori Y, Kondziolka D, Flickinger J, Logan T, Lunsford LD: Stereotactic radiosurgery for cerebral metastatic melanoma: factors affecting local disease control and survival. Int J Radiat Oncol Biol Phys 42: 581–589, 1998
Sneed PK, Lamborn KR, Forstner JM, McDermott MW, Chang S, Park E, Gutin PH, Phillips TL, Wara WM, Larson DA: Radiosurgery for brain metastases: is whole brain radiotherapy necessary? Int J Radiat Oncol Biol Phys 43: 549–558, 1999
Somoza S, Kondziolka D, Lunsford LD, Kirkwood JM, Flickinger JC: Stereotactic radiosurgery for cerebral metastatic melanoma. J Neurosurg 79: 661–666, 1993
Shirato H, Takamura A, Tomita M, Suzuki K, Nishioka T, Isu T, Kato T, Sawamura Y, Miyamachi K, Abe H, Miyasaka K: Stereotactic irradiation without whole brain irradiation for single brain metastasis. Int J Radiat Oncol Biol Phys 37: 385–391, 1997
Pirzkall A, Debus J, Lohr F, Fuss M, Rhein B, Engenhart-Cabillic R, Wannenmacher M: Radiosurgery alone or in combination with whole brain radiotherapy for brain metastases. J Clin Oncol 16: 3563–3569, 1998
Loeffler JS, Alexander E III: Radiosurgery for the treatment of intracranial metastases. In: Alexander E III, Loeffler JS, Lunsford LD (eds) Stereotactic Radiosurgery. McGraw-Hill, New York, 1993, pp 197–206
Kihlstrom L, Karlsson B, Lindquist C:Gammaknife surgery for cerebral metastases: implications for survival based on 16 years experience. Stereotact Funct Neurosurg 1: 45–50, 1993
Cho KH, Hall WA, Gerbi BJ, Higgins PD, Bohen M, Clark HB: Patient selection criteria for the treatment of brain metastases with stereotactic radiosurgery. J Neuro-Oncol 40: 73–86, 1998
Scott C, Gaspar L, Rotman M, Asbell S, Phillips T, Wasserman T, McKenna WG, Byhardt R: Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) trials [abstract]. Int J Radiat Oncol Biol Phys 32 (suppl 1): 207, 1995
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Chitapanarux, I., Goss, B., Vongtama, R. et al. Prospective Study of Stereotactic Radiosurgery Without Whole Brain Radiotherapy in Patients with Four or Less Brain Metastases: Incidence of Intracranial Progression and Salvage Radiotherapy. J Neurooncol 61, 143–149 (2003). https://doi.org/10.1023/A:1022173922312
Issue Date:
DOI: https://doi.org/10.1023/A:1022173922312